Mechanisms of Anabolic Osteoporosis Therapy

Status Recruiting

Clinical Trial Summary

The aim of this study is to investigate the effect of romosozumab on bone cells during early and late phases of treatment.

Clinical Trial Description

The investigators will perform paired iliac crest bone biopsies in postmenopausal women who meet standard romosozumab treatment indications and are being prescribed romosozumab by their treating physician. All study volunteers will have a bone biopsy procedure prior to starting therapy, and then an identical procedure at the contralateral side either 3-6 weeks ("early") or 6-8 months ("late") after starting therapy. This is not a randomized clinical trial testing the efficacy of a drug - the investigators will not be assigning volunteers to a specific osteoporosis therapy, though the investigators will randomize volunteers to either the early or late second biopsy. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05688969
Study type	Interventional
Source	Massachusetts General Hospital
Contact	Mackenzie Jordan
Phone	617-726-6129
Email	MRJORDAN@mgh.harvard.edu
Status	Recruiting
Phase	N/A
Start date	June 14, 2023
Completion date	December 2028

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT03931109` - Circulating miRNA in Primary Hyperparathyroidism
Not yet recruiting	`NCT03232476` - Effect of Mechanical Loading With PTH on Cortical Bone	Phase 4
Completed	`NCT02884401` - Peri-implant Bone Changes in Post-menopausal Osteoporotic Women	N/A
Completed	`NCT00073190` - Patient- and Physician-Based Osteoporosis Education	Phase 1
Completed	`NCT00402441` - Risedronate in the Prevention of Osteoporosis in Postmenopausal Women	Phase 4
Completed	`NCT03710889` - Early Effects of Abaloparatide on Tissue-Based Indices of Bone Formation and Resorption	Phase 3
Completed	`NCT00010712` - Effects of Black Cohosh on Menopausal Hot Flashes	Phase 2
Recruiting	`NCT05058976` - Romosozumab Use to Build Skeletal Integrity	Phase 4
Recruiting	`NCT05405894` - Efficacy of Zoledronic Acid to Prevent Bone Loss Following Denosumab Discontinuation
Recruiting	`NCT03337971` - Nutritional Supplement and Bone Health in Post-Menopausal Women	N/A
Completed	`NCT03701113` - Milk Protein and Bone Health in Postmenopausal Women	N/A
Completed	`NCT01381588` - The Prevalence of Osteoporotic Vertebral Compression Fractures (OVCF) in Korean Post Menopausal Women	N/A
Completed	`NCT00383422` - Study Comparing Arzoxifene With Raloxifene in Women After Menopause With Osteoporosis	Phase 3
Completed	`NCT00549965` - Satisfaction and Compliance of Risedronate in PMO	Phase 4
Completed	`NCT00035256` - Sequential Use of Teriparatide and Raloxifene HCl in the Treatment of Postmenopausal Women With Osteoporosis	Phase 4
Completed	`NCT01386281` - Julina Post-marketing Surveillance for Climacteric Symptoms in Japan
Completed	`NCT05266261` - Use of Ibandronate in Diabetic Patients	N/A
Recruiting	`NCT04964388` - Effect of GLP-1 Receptor Agonists on Trabecular Bone Score	Phase 2
Active, not recruiting	`NCT03623633` - Comparative Antiresorptive Efficacy Discontinuation of Denosumab	Phase 4
Recruiting	`NCT05575167` - Single or Repeat Zoledronate Versus Alendronate Following Denosumab (EUROpean Denosumab Effects Consolidation Study)